Allendale Pharma's Today Sponge Labeling Passes FDA Panel Muster
This article was originally published in The Gray Sheet
Executive Summary
Proposed labeling for Allendale Pharmaceuticals' Today sponge adequately conveys the risks associated with use of the female contraceptive albeit with some minor adjustments, FDA's Nonprescription Drugs Advisory Committee concluded at a July 12 meeting.